KDIGO 2017慢性肾脏病-矿物质和骨异常（CKD-MBD）诊断、评估、预防及治疗临床实践指南更新 - Suppr

Suppr

超能文献

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

出版信息

Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.

DOI:10.1016/j.kisu.2017.04.001

PMID:30675420

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6340919/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3698/6340919/b49bd2a6c6e0/fx16.jpg

相似文献

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.

KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Am J Kidney Dis. 2017 Dec;70(6):737-751. doi: 10.1053/j.ajkd.2017.07.019. Epub 2017 Sep 21.

Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.

Can J Kidney Health Dis. 2020 Aug 4;7:2054358120944271. doi: 10.1177/2054358120944271. eCollection 2020.

2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.

Kidney Int Rep. 2019 Sep 23;4(11):1523-1537. doi: 10.1016/j.ekir.2019.09.007. eCollection 2019 Nov.

Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). . 2017;7:1-59.

Kidney Int Suppl (2011). 2017 Dec;7(3):e1. doi: 10.1016/j.kisu.2017.10.001. Epub 2017 Nov 17.

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.

Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in China.

Kidney Dis (Basel). 2019 Oct;5(4):197-203. doi: 10.1159/000500053. Epub 2019 Jul 9.

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD.

BMC Nephrol. 2018 Sep 20;19(1):240. doi: 10.1186/s12882-018-1037-8.

Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.

Nefrologia. 2013;33 Suppl 1:1-28. doi: 10.3265/Nefrologia.pre2013.Feb.11945.

引用本文的文献

Chronic kidney disease in the primary care setting: A narrative review.

J Gen Fam Med. 2025 Jul 29;26(5):385-393. doi: 10.1002/jgf2.70054. eCollection 2025 Sep.

Efficacy of 12-month romosozumab monotherapy or combination with eldecalcitol in patients with osteoporosis with and without chronic kidney disease: A real-world retrospective study.

Biomed Rep. 2025 Aug 18;23(4):166. doi: 10.3892/br.2025.2044. eCollection 2025 Oct.

Development and validation of a nomogram for predicting hyperphosphatemia in non-dialysis patients with chronic kidney disease.

BMC Nephrol. 2025 Sep 2;26(1):512. doi: 10.1186/s12882-025-04445-0.

Pulse wave-driven machine learning for the non-invasive assessment of coronary artery calcification in patients with end-stage renal disease undergoing hemodialysis.

Biomed Eng Online. 2025 Aug 29;24(1):104. doi: 10.1186/s12938-025-01436-y.

Effect of Chinese herbal enema prescription on renal function, enterogenous uremic toxins and intestinal barrier function in stage 3 to 5 chronic kidney disease predialysis participants: A randomized controlled trial.

Medicine (Baltimore). 2025 Aug 8;104(32):e43791. doi: 10.1097/MD.0000000000043791.

Femoral artery calcification predicts hip fracture in maintenance hemodialysis patients.

Arch Osteoporos. 2025 Aug 9;20(1):112. doi: 10.1007/s11657-025-01536-1.

High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report.

BMC Nephrol. 2025 Aug 7;26(1):442. doi: 10.1186/s12882-025-04361-3.

Interventions to Reduce the Risk of Hypocalcemia After Parathyroidectomy for People With Advanced Chronic Kidney Disease: A Systematic Review.

Can J Kidney Health Dis. 2025 Jul 29;12:20543581251358144. doi: 10.1177/20543581251358144. eCollection 2025.

Clinical outcomes and dialysate calcium concentrations in Chinese patients on maintenance hemodialysis: a retrospective cohort study.

Ren Fail. 2025 Dec;47(1):2536194. doi: 10.1080/0886022X.2025.2536194. Epub 2025 Aug 4.

Proteinuria reduction by and safety of finerenone in Chinese patients with CKD without diabetes: a real-world retrospective study.

BMC Urol. 2025 Aug 2;25(1):189. doi: 10.1186/s12894-025-01897-2.

本文引用的文献

The Phosphate Content of Prescription Medication: A New Consideration.

Ther Innov Regul Sci. 2015 Nov;49(6):886-889. doi: 10.1177/2168479015592194.

Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1608-1613. doi: 10.1093/ndt/gfw468.

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.

J Am Soc Nephrol. 2017 Jun;28(6):1933-1942. doi: 10.1681/ASN.2016080855. Epub 2017 Feb 3.

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.

JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468.

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.

JAMA. 2017 Jan 10;317(2):146-155. doi: 10.1001/jama.2016.19456.

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.

Am J Nephrol. 2016;44(4):316-325. doi: 10.1159/000450766. Epub 2016 Sep 28.

Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

Kidney Int. 2016 Dec;90(6):1184-1190. doi: 10.1016/j.kint.2016.06.041. Epub 2016 Sep 18.

Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.

Am J Kidney Dis. 2016 Nov;68(5):691-702. doi: 10.1053/j.ajkd.2016.05.015. Epub 2016 Jul 22.

Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.

PLoS One. 2016 Jun 8;11(6):e0156891. doi: 10.1371/journal.pone.0156891. eCollection 2016.

Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: A Randomized Controlled Trial.

Am J Transplant. 2016 Jun;16(6):1882-91. doi: 10.1111/ajt.13692. Epub 2016 Feb 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验